logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Cancer Prevention 1st Edition Peter Greenwald Md Phd Auth

  • SKU: BELL-4398000
Cancer Prevention 1st Edition Peter Greenwald Md Phd Auth
$ 31.00 $ 45.00 (-31%)

0.0

0 reviews

Cancer Prevention 1st Edition Peter Greenwald Md Phd Auth instant download after payment.

Publisher: Springer-Verlag Berlin Heidelberg
File Extension: PDF
File size: 3.34 MB
Pages: 250
Author: Peter Greenwald MD, PhD (auth.), Prof. Dr. med. Hans-Jörg Senn, Prof. Dr. med. Ursula Kapp (eds.)
ISBN: 9783540376958, 9783540376965, 354037695X, 3540376968
Language: English
Year: 2007
Edition: 1

Product desciption

Cancer Prevention 1st Edition Peter Greenwald Md Phd Auth by Peter Greenwald Md, Phd (auth.), Prof. Dr. Med. Hans-jörg Senn, Prof. Dr. Med. Ursula Kapp (eds.) 9783540376958, 9783540376965, 354037695X, 3540376968 instant download after payment.

This volume contains the main proceedings of the fourth international conference on "Cancer Prevention 2006," which was held during February 16–18, 2006, in St. Gallen, Switzerland. Written by international experts in the field, the book comprises a comprehensive update on the most recent developments in the upsurging fields of molecular biology and cancer genetics and their interactions with clinical epidemiology and cancer prevention at various levels: genetic/biologic predisposition and definition of high-risk groups; preclinical models and tumor prevention; prospects of surrogate endpoints and biomarkers; progress in imaging and detection of neoplastic precursor lesions; problems with Cox-2 inhibitors in tumor chemoprevention; primary and secondary prevention of gynecological, breast, gastrointestinal and genitourinary cancers. In addition, the future prospects of cancer chemoprevention are discussed.

Related Products